摘要
世界范围内肿瘤大数据已经取得了长足的进步,总结了肿瘤大数据在抗肿瘤药物应用中的研究进展,包括肿瘤流行病学、肿瘤早期诊断、新靶点和新适应症的发现、不良反应的信号发掘、患者预后模型的构建,以及肿瘤大数据存在的不足,如数据的采集、可信度、保存、安全性等。
Tumor big data has made great progress worldwide. The research progress of tumor big data in the application of tumor medicine including tumor epidemiology, early diagnosis, the discovery of new target and indications, signal discovery of adverse reactions, construction of patient prognosis model, and the shortage of tumor big data such as data collection, reliability, storage, and security, etc was summarized in this paper.
作者
周海辉
张海霞
严婷婷
葛卫红
ZHOU Hai-hui;ZHANG Hai-xia;YAN Ting-ting;GE Wei-hong(Division of Clinical Pharmacy,Department of Pharmacy,Drum Tower Hospital Affiliated to Medical School of Nanjing University,Nanjing 210008,China;Cancer Center,Drum Tower Hospital Affiliated to Medical School of Nanjing University,Nanjing 210008,China)
出处
《现代药物与临床》
CAS
2018年第11期3079-3082,共4页
Drugs & Clinic
基金
国家自然科学基金资助项目(81601153)
江苏省自然科学基金资助项目(BK20150104)
南京市医学科技发展基金资助项目(YKK16083)
南京市科技发展计划项目(201503020)
关键词
肿瘤大数据
抗肿瘤药物
精准医学
tumor big data
anticancer drugs
precision medicine